Millennium Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-250,560
| Closed | -$52.7K | – | 6782 |
|
|
2023
Q2 | $52.7K | Sell |
250,560
-120,983
| -33% | -$21K | ﹤0.01% | 5464 |
|
|
2023
Q1 | $59K | Sell |
371,543
-518,585
| -58% | -$230K | ﹤0.01% | 5570 |
|
|
2022
Q4 | $494K | Buy |
890,128
+48,795
| +6% | +$41.5K | ﹤0.01% | 4756 |
|
|
2022
Q3 | $1M | Sell |
841,333
-1,031,090
| -55% | -$1.11M | ﹤0.01% | 4344 |
|
|
2022
Q2 | $1.18M | Buy |
1,872,423
+1,814,022
| +3,106% | +$1.39M | ﹤0.01% | 4217 |
|
|
2022
Q1 | $67K | Sell |
58,401
-684,870
| -92% | -$818K | ﹤0.01% | 6309 |
|
|
2021
Q4 | $1.67M | Sell |
743,271
-2,208,665
| -75% | -$5.54M | ﹤0.01% | 3937 |
|
|
2021
Q3 | $10.1M | Sell |
2,951,936
-96,497
| -3% | -$297K | 0.01% | 2031 |
|
|
2021
Q2 | $9.12M | Sell |
3,048,433
-167,065
| -5% | -$529K | 0.01% | 2029 |
|
|
2021
Q1 | $10.4M | Buy |
3,215,498
+2,341,544
| +268% | +$7.81M | 0.01% | 1735 |
|
|
2020
Q4 | $1.85M | Buy |
873,954
+841,800
| +2,618% | +$1.39M | ﹤0.01% | 3298 |
|
|
2020
Q3 | $38 | Buy |
32,154
+6,503
| +25% | +$6.68K | ﹤0.01% | 4316 |
|
|
2020
Q2 | $23K | Buy |
+25,651
| New | +$24.4K | ﹤0.01% | 4092 |
|
|
2019
Q2 | – | Sell |
-113,258
| Closed | -$213K | – | 4601 |
|
|
2019
Q1 | $213K | Buy |
113,258
+43,493
| +62% | +$63.6K | ﹤0.01% | 3707 |
|
|
2018
Q4 | $82K | Sell |
69,765
-24,545
| -26% | -$44.1K | ﹤0.01% | 3564 |
|
|
2018
Q3 | $256K | Sell |
94,310
-15,845
| -14% | -$32.8K | ﹤0.01% | 3547 |
|
|
2018
Q2 | $210K | Sell |
110,155
-217,205
| -66% | -$439K | ﹤0.01% | 3542 |
|
|
2018
Q1 | $687K | Sell |
327,360
-871,494
| -73% | -$1.87M | ﹤0.01% | 2886 |
|
|
2017
Q4 | $2.43M | Buy |
1,198,854
+614,806
| +105% | +$1.28M | ﹤0.01% | 2164 |
|
|
2017
Q3 | $777K | Sell |
584,048
-220,488
| -27% | -$274K | ﹤0.01% | 2643 |
|
|
2017
Q2 | $1.26M | Buy |
804,536
+532,143
| +195% | +$1.03M | ﹤0.01% | 2329 |
|
|
2017
Q1 | $880K | Sell |
272,393
-549,843
| -67% | -$1.35M | ﹤0.01% | 2472 |
|
|
2016
Q4 | $1.11M | Buy |
822,236
+667,894
| +433% | +$872K | ﹤0.01% | 2190 |
|
|
2016
Q3 | $241K | Sell |
154,342
-560,021
| -78% | -$860K | ﹤0.01% | 2909 |
|
|
2016
Q2 | $950K | Sell |
714,363
-85,998
| -11% | -$402K | ﹤0.01% | 2194 |
|
|
2016
Q1 | $4.22M | Sell |
800,361
-655,924
| -45% | -$4.01M | 0.01% | 1345 |
|
|
2015
Q4 | $11.4M | Buy |
1,456,285
+1,274,197
| +700% | +$11M | 0.02% | 859 |
|
|
2015
Q3 | $1.54M | Sell |
182,088
-274,133
| -60% | -$2.53M | ﹤0.01% | 2070 |
|
|
2015
Q2 | $5M | Sell |
456,221
-435,001
| -49% | -$5.58M | 0.01% | 1396 |
|
|
2015
Q1 | $12.5M | Sell |
891,222
-349,923
| -28% | -$5.35M | 0.02% | 905 |
|
|
2014
Q4 | $21M | Buy |
1,241,145
+32,165
| +3% | +$468K | 0.04% | 583 |
|
|
2014
Q3 | $16.2M | Buy |
1,208,980
+737,926
| +157% | +$8.79M | 0.04% | 604 |
|
|
2014
Q2 | $6M | Sell |
471,054
-10,976
| -2% | -$114K | 0.02% | 1095 |
|
|
2014
Q1 | $5.73M | Buy |
482,030
+120,649
| +33% | +$1.62M | 0.02% | 1136 |
|
|
2013
Q4 | $4.99M | Sell |
361,381
-483,111
| -57% | -$6.82M | 0.02% | 1171 |
|
|
2013
Q3 | $14.7M | Buy |
844,492
+733,028
| +658% | +$14M | 0.05% | 508 |
|
|
2013
Q2 | $1.8M | Buy |
+111,464
| New | +$3.45M | 0.01% | 1646 |
|
Other funds holding INFI
Millennium Management's INFI Position: Q3 2023 in Review
Millennium Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 250,560 shares — an estimated $52.7K sold.
Millennium Management first reported a position in INFI in Q2 2013 and held it in 37 quarters. The position peaked at $21M in Q4 2014. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Millennium Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Millennium Management sold 250,560 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $52.7K.
- Millennium Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 37 quarters.
- Millennium Management's Infinity Pharmaceuticals, Inc. position peaked at $21M in Q4 2014.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.